ANJULI SINHA: Open Payments
NPI 1205231032 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 56 payments from 10 companies in 2025. Trend: 2023 $441 · 2024 $554 · 2025 $1,112
Food & beverage: $1,112
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $529 |
| Amgen Inc. | 15 | $189 |
| ABBVIE INC. | 10 | $144 |
| Novo Nordisk Inc | 4 | $90 |
| Lilly USA, LLC | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Tempus AI, Inc | 1 | $16 |
Products named: BREZTRI, VRAYLAR, OTEZLA, FARXIGA, Wegovy, JARDIANCE, AIRSUPRA, Qelbree.
Industry payments across TX — which companies pay providers there.
